SOA
EFTRW

Sea Otter Advisors’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Sea Otter Advisors’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,000
Closed -$3.2K – 80
2023
Q4 		$3.69K Hold
25,000
– – ﹤0.01% 150
2023
Q3 		$1.9K Hold
25,000
– – ﹤0.01% 225
2023
Q2 		$4.34K Hold
25,000
– – ﹤0.01% 207
2023
Q1 		$3.23K Buy
+25,000
New +$3.98K ﹤0.01% 225

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sea Otter Advisors's EFTRW Position: Q1 2024 in Review

Sea Otter Advisors sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q1 2024, closing a stake of 25,000 shares — an estimated $3.2K sold.

Sea Otter Advisors first reported a position in EFTRW in Q1 2023 and held it in 4 quarters. The position peaked at $4.34K in Q2 2023. 12 funds tracked by Wall St. Rank hold EFTRW as of Q1 2024.

  • Sea Otter Advisors reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • Sea Otter Advisors sold 25,000 eFFECTOR Therapeutics, Inc. Warrant shares in Q1 2024, an estimated $3.2K.
  • Sea Otter Advisors first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2023 and held it in 4 quarters.
  • Sea Otter Advisors's eFFECTOR Therapeutics, Inc. Warrant position peaked at $4.34K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q1 2024.

Based on Sea Otter Advisors's 13F filing for Q1 2024, filed 15 May 2024.